  Although the outbreak of human monkeypox (Mpox) caused by the monkeypox virus
(MPXV) has slowed down around the world, little is known about this
epidemic-like disease. To identify and re-examine the underlying pattern of the
disease through a modified logistic growth model, Mpox data set of the United
States from 10 May 2022 to 31 December 2022 was used in this study. The main
focus is on the two non-pharmaceutical interventions (policies for reducing
human-to-human, and animal-to-human transmissions) which were applied to
understand their significance on the epidemic. The interventions are used as
control parameters in the model with a view to analyzing the strengths of such
controls in minimizing the infected cases. The model reveals a complying
acceptance to the United States data. The findings disclose that preventive
measures could play important roles in controlling the deadly spread of the
transmission in the year of 2022. During the transmission period, better
outcomes could have been possible to achieve in the US if both controls were
brought to action simultaneously. Our model reflects that to prevent the
outbreak of Mpox and/or any similar diseases from a community in future, the
continuous application of the preventive strategies displayed through the model
might be an effective tool. Moreover, such strategies could play supporting
roles during pre-and/or post-vaccination periods.
